Table 2 PLASMIC score and ADAMTS13 activity characteristics of patients in primary analysis from the PINC AI™ database (n = 110)
Characteristics | Overall | ADAMTS13 activity | PLASMIC Score | ||
|---|---|---|---|---|---|
< 10%e | ≥ 10%f | 0 to 5 | 6 to 7 | ||
(n = 110) | (n = 21) | (n = 89) | (n = 83) | (n = 27) | |
PLASMIC Score components, n (%) | |||||
Platelet count < 30 × 109 / La | 41 (37.3) | 18 (85.7) | 23 (25.8) | 18 (21.7) | 23 (85.2) |
Hemolysisa, b | 64 (58.2) | 19 (90.5) | 45 (50.6) | 39 (47) | 25 (92.6) |
No active cancer in the past year | 68 (61.8) | 11 (52.4) | 57 (64.0) | 45 (54.2) | 23 (85.2) |
No history of solid organ or stem cell transplant | 104 (94.5) | 21 (100) | 83 (93.3) | 77 (92.8) | 27 (100) |
Mean corpuscular volume < 9 × 10− 14 La, c | 72 (65.5) | 14 (66.7) | 58 (65.2) | 50 (60.2) | 22 (81.5) |
International Normalization Ratio < 1.5a | 94 (85.5) | 20 (95.2) | 74 (83.1) | 68 (81.9) | 26 (96.3) |
Creatinine < 2.0 mg / dLd | 58 (52.7) | 20 (95.2) | 38 (42.7) | 32 (38.6) | 26 (96.3) |
ADAMTS13 activity level, %a | |||||
Median (Q1, Q3) | 57.5 (35, 83) | 5 (5, 5) | 67 (48, 85) | 64 (46, 84) | 5 (5, 55) |